Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...
After over a decade of leading the MRC-University of Glasgow Centre for Virus Research (CVR), Professor Massimo Palmarini is stepping down as Dir ...